Twist Bioscience Corp Balance Sheet
TWST / Health Care|9 years of annual SEC 10-K data (FY2017-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
Twist Bioscience Corp had $642M in total assets and $473M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $183.0M | $226.3M | $286.5M | $378.7M | $465.8M | $93.7M | $46.7M | $80.8M | $31.2M |
| Accounts Receivable | $57.0M | $34.9M | $44.1M | $40.3M | $28.5M | $26.4M | $12.1M | $5.4M | - |
| Inventory | $28.3M | $24.1M | $32.1M | $39.3M | $31.8M | $12.3M | $7.3M | $6.0M | - |
| Current Assets | $333.0M | $346.8M | $424.3M | $596.5M | $546.5M | $334.9M | $160.1M | $95.7M | - |
| PP&E (Net) | $102.3M | $102.5M | $131.8M | $139.4M | $44.1M | $25.5M | $20.8M | $12.3M | - |
| Goodwill | $82.2M | $85.8M | $85.8M | $85.8M | $22.4M | $1.1M | $1.1M | $1.1M | - |
| Total Assets | $641.9M | $614.3M | $776.4M | $961.4M | $702.1M | $398.9M | $187.0M | $115.8M | - |
| Current Liabilities | $91.4M | $71.0M | $73.3M | $90.7M | $63.1M | $36.0M | $30.4M | $18.5M | - |
| Total Debt | - | - | - | - | - | $1.4M | $4.4M | $7.2M | - |
| Shareholders' Equity | $473.0M | $472.7M | $623.4M | $789.4M | $580.8M | $336.3M | $152.1M | -$201.4M | -$133.4M |